PHiD-CV effectiveness against invasive pneumococcal disease caused by serotype 19A

Vaccine

Volumn 33, Issue 3, 2015, Pages 415-

  Moreira, Marta ^a   Guevara, Javier Nieto ^b   Caceres, Diana ^b  

^a GSK   (Belgium)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; PENICILLIN DERIVATIVE; PNEUMOCOCCAL HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE; UNCLASSIFIED DRUG;

BACTERIUM ISOLATE; DISEASE SURVEILLANCE; DRUG EFFICACY; HIGH RISK POPULATION; HUMAN; LETTER; NONHUMAN; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; CLASSIFICATION; MICROBIOLOGY; STREPTOCOCCUS PNEUMONIAE;

HUMANS; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84921992884     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.10.056     Document Type: Letter

References (5)

1. Hausdorff W.P., Mrkvan T., Moreira M., Ruiz Guiñazú J., Borys D. Five years of post-licensure experience with the 10-valent pneumococcal non-typeable Haemophilus influenza protein D conjugate vaccine (PHiD-CV): a review. e-Poster P-286 presented at the 9th International Symposium on Pneumococci and Pneumococcal Diseases [Abstract ISPPD - 0393 Pneumonia 2014; 3:286] 2014, http://isppd.meetingxpert.net/swf/poster_viewer.aspx?ID=90669 [accessed 07.05.14].
2. Dutch Reference Laboratory for Bacterial Meningitis: annual reports [accessed 27.05.14]. http://www.amc.nl/web/Research/Departments/Overview/Medical-Microbiology/Medical-Microbiology/Current-research/Reference-Laboratory-for-Bacterial-Meningitis.htm%3Fprint=true.
3. Domingues C.M., Verani J.R., Montenegro Renoiner E.I., de Cunto Brandileone M.C., Flannery B., deOliveira L.H., et al. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med 2014, 2:464-471.
4. Deceuninck G., De Wals P. Effectiveness of three pneumococcal conjugate vaccines (PCVs) to prevent invasive pneumococcal disease (IPD) in Quebec, Canada. e-Poster P-271 presented at the 9th International Symposium on Pneumococci and Pneumococcal Diseases [Abstract ISPPD - 0333 Pneumonia 2014; 3:286] 2014, http://isppd.meetingxpert.net/swf/poster_viewer.aspx?ID=90654 [accessed 07.05.14].
5. 2012 Esquema de vacunacion actualizado colombia: as of January 2012 PCV10 in the UMV (2, 4, 12 months). Cfr Anexo 7: Ministerio de salud y protección social/Dirección de Promoción y Prevención/Subdirección de enfermedades transmisibles/Programa Ampliado de Inmunizaciones.